Preview

Медицинский алфавит

Расширенный поиск
Доступ открыт Открытый доступ  Доступ закрыт Доступ платный или только для Подписчиков

Нарушения биологических ритмов при депрессии

https://doi.org/10.33667/2078-5631-2019-2-19(394)-5-10

Полный текст:

Аннотация

Депрессия относится к заболеваниям, сопровождающимся выраженными медико-социальными последствиями, к которым относятся инвалидность, снижение социального функционирования и суициды. Существует ряд доказательств тесной связи депрессивных проявлений с нарушениями циркадного периодизма и функций супрахиазменных ядер гипоталамуса — ведущего водителя биологических ритмов. Данная статья является литературным обзором, посвященным понятию биологических ритмов, хронотипа, десинхроноза, их роли в развитии и течении депрессии, опыте применения хронобиотических препаратов при депрессивном расстройстве.

Об авторах

М. Г. Полуэктов
ФГАОУ ВО «Первый Московский государственный медицинский университет имени И. М. Сеченова (Сеченовский университет)» Минздрава России
Россия

к. м. н., доцент, кафедра нервных болезней и нейрохирургии

г. Москва



П. М. Хаджаева
ФГАОУ ВО «Первый Московский государственный медицинский университет имени И. М. Сеченова (Сеченовский университет)» Минздрава России
Россия

аспирант, кафедра нервных болезней и нейрохирургии

г. Москва



Список литературы

1. Хронобиология и хрономедицина / Под ред. Ф. И. Комарова — М., Медицина, 1989, 400 c.

2. Müller MJ, Haag A. The concept of chronotypes and its clinical importance for depressive disorders. Int J Psychiatry Med. 2018; 53 (3): 224–240.

3. Губин Г. Д., Губин Д. Г. Классификация десинхронозов по причинному фактору и механизмам развития. Два принципа хронотерапии десинхроноза // Фундаментальные исследования. 2004; 1: 50–50.

4. Berdynaj D., Boudissa S. N., Grieg M. S. et al. Effect of chronotype on emotional processing and risk taking. Chronobiol Int. 2016; 33 (4): 406–18.

5. Gaspar-Barba E, Calati R, Cruz-Fuentes CS, et al. Depressive symptomatology is influenced by chronotypes. J Affect Disord 2009; 119: 100–106.

6. Rahafar A., Maghsudloo M., Farhangnia S. et al. The role of chronotype, gender, test anxiety, and conscientiousness in academic achievement of high school students. Chronobiol Int. 2016; 33 (1): 1–9.

7. Rosenthal NE, Sack DA, Gillin JC, et al. Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatr. 1984; 41: 72–80.

8. Chan JW, Lam SP, Li SX, et al. Eveningness and insomnia: independent risk factors of nonremission in major depressive disorder. Sleep 2014; 37: 911–917.

9. Chung JK, Lee KY, Kim SH, et al. Circadian rhythm characteristics in mood disorders: comparison among bipolar I disorder, bipolar II disorder and recurrent major depressive disorder. Clin Psychopharmacol Neurosci 2012; 10: 110–116.

10. Merikanto I, Lahti T, Kronholm E, et al. Evening types are prone to depression. Chronobiol Int 2013; 30: 719–725.

11. Merikanto I, Kronholm E, Peltonen M, et al. Circadian preference links to depression in general adult population. J Affect Disord 2015; 188: 143–148.

12. Merikanto I., Suvisaari J., Lahti T., Partonen T. Eveningness relates to burnout and seasonal sleep and mood problems among young adults. Nord J Psychiatry. 2016; 70 (1): 72–80.

13. Fares S., Hermens D. F., Naismith S. L. et al. Clinical correlates of chronotypes in young persons with mental disorders. Chronobiol Int. 2015; 32 (9): 1183–91.

14. Selvi Y, Aydin A, Boysan M, et al. Associations between chronotype, sleep quality, suicidality, and depressive symptoms in patients with major depression and healthy controls. Chronobiol Int 2010; 27: 1813–1828.

15. Souetre E., Salvati E., Belugou J. L. et al. Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality. Psychiatry Res 1989; 28: 263–278.

16. Андрушкявичус С. И. Циркадианные изменения параметров вегетативной активности при депрессиях. Социальная и клиническая психиатрия. 2005; 15 (3): 11–15.

17. Szymanska A., Rabe-Jablonska J., Karasek M. Diurnal profile of melatonin concentrations in patients with major depression: relationship to the clinical manifestation and antidepressant treatment. Neuroendocrinol Lett. 2001; 22: 192–198.

18. Duncan WC Jr. Circadian rhythms and the pharmacology of affective illness. Pharmacol Ther. 1996; 71 (3): 253–312.

19. Pflug B, Johnsson A, Ekse AT. Manic-depressive states and daily temperature. Some circadian studies. Acta Psychiatr Scand. 1981; 63 (3): 277–89.

20. Schulz H, Lund R. Sleep onset REM episodes are associated with circadian parameters of body temperature. A study in depressed patients and normal controls. Biol Psychiatry. 1983; 18 (12): 1411–26.

21. Souetre E, Salvati E, Wehr TA, Sack DA, Krebs B, Darcourt G. Twenty-four-hour profiles of body temperature and plasma TSH in bipolar patients during depression and during remission and in normal control subjects. Am J Psychiatry. 1988; 145 (9): 1133–7.

22. Buckley TM, Schatzberg AF. A pilot study of the phase angle between cortisol and melatonin in major depression — a potential biomarker? J Psychiatr Res. 2010; 44 (2): 69–74.

23. Rubin RT, Heist EK, McGeoy SS, Hanada K, Lesser IM. Neuroendocrine Aspects of Primary Endogenous Depression: XI. Serum Melatonin Measures in Patients and Matched Control Subjects. Arch Gen Psychiatry. 1992; 49 (7): 558–567.

24. Wetterberg L. Melatonin and application. Reproduction Nutrition Development 1999; 39: 367–382.

25. Wetterberg L. Clinical importance of melatonin. Prog Brain Res. 1979; 52: 539–47.

26. Carman J. S., Post R. S., Buswell R., Goodwin F. K. Negative effects of melatonin on depression. Am J Psychiat 1976; 133: 1181–1186.

27. Dalton E. J., Rotondi D., Levitan R. D. et al. Use of slow-release melatonin in treatment-resistant depression. J Psychiat Neurosci 2000; 25: 48–52

28. Dolberg O. T., Hirschmann S., Grunhaus L. Melatonin for the treatment of sleep disturbances in major depressive disorder. Am J Psychiat 1998; 155: 1119–1121.

29. Lewy AJ, Lefler BJ, Emens JS, Bauer VK. The circadian basis of winter depression. Proc Natl Acad Sci USA 2006; 103: 7414–7419.

30. Fava M, Targum SD, Nierenberg AA et al. An exploratory study of combination buspirone and melatonin SR in major depressive disorder (MDD): a possible role for neurogenesis in drug discovery. J Psychiatr Res 2012; 46: 1553–1563

31. Hirsch-Rodriguez E, Imbesi M, Manev R, Uz T, Manev H. The pattern of melatonin receptor expression in the brain may influence antidepressant treatment. Med Hypotheses. 2007; 69 (1): 120–4.

32. Wirz-Justice A. From the basic neuroscience of circadian clock function to light therapy for depression: on the emergence of chronotherapeutics. J Affect Disord. 2009 Aug; 116 (3): 159–60.

33. Gross PK, Nourse R, Wasser TE. Ramelteon for insomnia symptoms in a community sample of adults with generalized anxiety disorder: an open label study. J Clin Sleep Med. 200915; 5 (1): 28–33.

34. McElroy SL, Winstanley EL, Martens B, Patel NC, Mori N, Moeller D, McCoy J, Keck PE Jr. A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbance. Int Clin Psychopharmacol. 2011; 26 (1): 48–53.

35. Norris ER, Karen Burke, Correll JR, Zemanek KJ, Lerman J, Primelo RA, Kaufmann MW. A double-blind, randomized, placebo-controlled trial of adjunctive ramelteon for the treatment of insomnia and mood stability in patients with euthymic bipolar disorder. J Affect Disord. 2013 Jan 10; 144 (1–2): 141–7.

36. Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder (MAGELLAN). Электронный документ по состоянию на 20.05.19. www.clinicaltrials.gov/ct2/show/study/NCT01428661?term=Major+Depressive+Disorder++and+tasimelteon&rank=1

37. Quera Salva MA, Vanier B, Laredo J, Hartley S, Chapotot F, Moulin C, Lofaso F, Guilleminault C. Major depressive disorder, sleep EEG and agomelatine: an open-label study. Int J Neuropsychopharmacol. 2007; 10 (5): 691–6.

38. Kasper S, Hajak G, Wulff K, Hoogendijk WJ, Montejo AL, Smeraldi E, Rybakowski JK, Quera-Salva MA, Wirz-Justice AM, Picarel-Blanchot F, Baylé FJ. Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline. J Clin Psychiatry. 2010; 71 (2): 109–20.


Для цитирования:


Полуэктов М.Г., Хаджаева П.М. Нарушения биологических ритмов при депрессии. Медицинский алфавит. 2019;2(19):5-10. https://doi.org/10.33667/2078-5631-2019-2-19(394)-5-10

For citation:


Poluektov M.G., Khadzhaeva P.M. Biological rhythm disturbances in depression. Medical alphabet. 2019;2(19):5-10. (In Russ.) https://doi.org/10.33667/2078-5631-2019-2-19(394)-5-10

Просмотров: 68


ISSN 2078-5631 (Print)